In an interview with the New York Times, Jon W. Dudas, director of the USPTO, voiced his support for the proposed rule changes currently being sought before the House and the Senate. The amendments include stricter disclosure requirements for applicants and public scrutiny of applications. Mr. Dudas underlined the USPTO's commitment to patent quality and argued that the proposed rule changes would result in higher patent quality and decreased patent litigation. Mr. Dudas also mentioned that the USPTO has been instituting its own quality initiatives in recent years. Those initiatives are partly responsible for a recent decline in patent applications approved. Referring to that decline, Mr. Dudas stated: "We've taken steps, and the result has been that a lot more patents are rejected…but those numbers also tell you there are a lot of bad patent applications."
By registering as a free NYTimes.com member, you can access the full press report at:
* For additional information on the planned U.S. proposed rule changes, see the May issue of Pharmacapsules or go to: